20.30EUR0.00%Mkt Cap: 3.32B $P/E: 21.371d ago
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a g…
Industry Peers
Medical Instruments & Supplies$142.49BUSDP/E 48.8
$84.67BUSDP/E 34.0
$73.25BUSDP/E 36.1
$44.07BUSDP/E 27.9
$31.69BUSDP/E 42.2
$29.41BUSDP/E 19.6
$25.61BUSDP/E 48.5
$19.82BUSDP/E 67.9
$18.23BUSDP/E 44.9
$18.54BUSDP/E 105.1
$14.74BUSDP/E 83.6
$13.59BUSDP/E 44.2
$14.26BUSDP/E 61.9
$14.15BUSDP/E 10.0
$12.78BUSDP/E 30.0
$12.06BUSD
$8.60BUSDP/E 23.1
$8.38BUSDP/E 165.1
$7.69BUSD
$5.63BUSDP/E 23.0
$5.99BUSDP/E 1931.7
$4.53BUSDP/E 30.5
$4.51BUSDP/E 32.6
$4.46BUSD
$4.39BUSDP/E 65.8
$4.03BUSDP/E 40.3
$4.05BUSDP/E 87.2
$3.67BUSDP/E 16.5
$3.39BUSDP/E 2759.0
$2.85BUSDP/E 21.9
$2.63BUSD
$2.77BUSD
$2.35BUSDP/E 37.9
$1.95BUSDP/E 36.0
$1.89BUSD
$1.80BUSD
$1.48BUSD
$1.44BUSD
$1.29BUSDP/E 74.9
$1.41BUSD
$1.23BUSD
$1.09BUSD
$752.64MUSDP/E 16.0
$811.83MUSD
$756.96MUSDP/E 14.8
$671.62MUSDP/E 39.2
$660.94MUSDP/E 55.9
$584.44MUSD
$360.76MUSDP/E 21.2
$354.68MUSDP/E 17.1
$272.64MUSD
$245.88MUSDP/E 13.6
$232.03MUSDP/E 422.0
$211.00MUSDP/E 35.6
$228.42MUSDP/E 21.2
$198.25MUSDP/E 23.8
$198.75MUSDP/E 1.8
$194.76MUSD
$188.63MUSDP/E 16.3
$160.12MUSD
$164.06MUSD
$123.68MUSDP/E 39.3
$115.11MUSD
$120.22MUSD
$107.50MUSD
$61.36MUSDP/E 6.4
$59.94MUSD
$48.70MUSD
$40.82MUSDP/E 53.7
$41.23MUSDP/E 41.0
$37.15MUSD
$32.43MUSD
$26.84MUSD
$25.35MUSDP/E 176.7
$20.69MUSD
$18.82MUSD
$14.75MUSD
$14.58MUSD
$13.43MUSD
$9.21MUSD
$7.52MUSDP/E 12.9
$7.46MUSD
$5.06MUSD
$4.00MUSD
$465.9KUSD
$138.6KUSD
Indicators:|
Key Statistics
Company
Market Cap3.32B $
Enterprise Value3.62B $
Revenue (TTM)1.08B $
Gross Profit361.37M $
Net Income (TTM)159.19M $
Revenue/Share7.188 USD
Last Price20.30 EUR
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees4.8K
CountryDE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINDE000A3ENQ51
Valuation
P/E (Trailing)21.37
P/E (Forward)19.00
PEG—
EV/EBITDA13.01
EV/Revenue3.36
P/S3.08
P/B3.24
EPS (TTM)0.95
EPS (Forward)1.07
52W Range
12.6256% of range26.35
52W High26.35 EUR
52W Low12.62 EUR
Profitability
Gross Margin33.71%
Oper. Margin15.95%
EBITDA Margin25.85%
Profit Margin14.85%
ROE16.42%
ROA9.16%
Growth
Revenue Growth-1.50%
Earnings Growth-16.00%
Cash Flow & Leverage
Operating CF195.57M $
CapEx (TTM)157.34M $
FCF Margin-3.30%
FCF Yield-1.07%
Net Debt297.86M $
Net Debt/EBITDA1.07
Balance Sheet
Debt/Equity0.09
Current Ratio1.59
Quick Ratio0.69
Book Value/Sh6.256 EUR
Cash/Share0.1850 EUR
Dividends
Fwd Div Rate0.1800 EUR
Trail. Div Rate0.1800 EUR
Div. Yield0.89%
5Y Avg Yield—
Payout Ratio18.95%
Ex-Div DateFeb 4, 2026
Pay Date—
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)20.43 EUR
Upside (mean)+0.7%
Target Range13.00 EUR – 25.90 EUR
€13.00+0.7% to mean€25.90
# Analysts12
Ownership
Shares Out.150.61M
Float34.64M
Insiders77.00%
Institutions19.42%
Technical
SMA 5017.40 (+16.6%)
SMA 20016.24 (+25.0%)
Beta0.95
S&P 52W Chg20.25%
Avg Vol (30d)62.63K
Avg Vol (10d)98.73K
Technical Indicators
RSI (14)69.4
MACD0.9180
MACD Signal0.6609
MACD Hist.+0.2570
BB Upper21.23 EUR
BB Middle18.26 EUR
BB Lower15.29 EUR
BB Width32.52%
ATR (14)0.8311 EUR
Vol Ratio (20d)0.84x